Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.945 SEK | +2.73% | +7.49% | +27.67% |
Apr. 08 | Oncozenge AB Appoints Paolo Bossi as Member of the Advisory Board | CI |
Apr. 04 | OncoZenge Announces Read-Out of Positive Stability Data for BupiZenge | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 46.21M 499M |
---|---|---|---|---|---|
Net income 2024 * | -8M -86.37M | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | 3M 32.39M | Net cash position 2025 * | 3M 32.39M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.8
x | P/E ratio 2025 * |
-
| Employees | 2 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 40.35% |
1 day | +2.73% | ||
1 week | +7.49% | ||
Current month | +6.05% | ||
1 month | +8.53% | ||
3 months | -20.78% | ||
6 months | +51.73% | ||
Current year | +27.67% |
Managers | Title | Age | Since |
---|---|---|---|
Stian Kildal
CEO | Chief Executive Officer | - | 23-09-12 |
Michael Owens
DFI | Director of Finance/CFO | 68 | 23-10-11 |
Markus Jerling
CTO | Chief Tech/Sci/R&D Officer | 72 | 21-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christoph Nowak
BRD | Director/Board Member | 38 | 23-09-08 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 3.945 | +2.73% | 48,293 |
24-05-03 | 3.84 | -1.41% | 12,097 |
24-05-02 | 3.895 | +4.70% | 25,754 |
24-04-30 | 3.72 | +1.36% | 24,305 |
Delayed Quote Nasdaq Stockholm, May 06, 2024 at 10:14 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+27.67% | 4.16M | |
+31.52% | 662B | |
+21.96% | 546B | |
-5.21% | 359B | |
+17.02% | 323B | |
+5.01% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+3.98% | 167B |
- Stock Market
- Equities
- ONCOZ Stock